Study on Immunotherapy-related Biomarkers of Small-cell Lung Cancer
LI Yu-yan
LI Shan-shan
FAN Li
ZHANG Bin
Jilin Kingmed for Clinical Laboratory Co.,Ltd.,Changchun Jilin 130000,China
摘要：The prognosis of small cell lung cancer is poor. Almost all patients have a tendency for tumor spreading to the whole body when they are diagnosed. Therefore, the combination of radiotherapy and chemotherapy is the main treatment, and surgical treatment is only implemented in a small number of limited patients. In recent years, there has been no obvious breakthrough in the treatment of small cell lung cancer, and the overall poor prognosis has not changed. With the development of medical technology, immune checkpoint inhibitors are gradually applied to the treatment of small-cell lung cancer, but the overall effect is limited. How to screen the beneficiary population to fur-ther improve the effect of immunotherapy is the key issue in the treatment of small-cell lung cancer.
机标关键词：immunotherapycancerstudybiomarkerslungrelatedsmall-cell
分类号：R734.2(呼吸系肿瘤)
论文发表日期：2022-03-30
在线出版日期：2025-08-15（本平台首次上网日期，不代表文献的发表时间）
页数：6( 27-32 )
英文信息